BLOCKING THE INHIBITORY CD94/NKG2A NK CELL RECEPTOR WITH A NOVEL ANTI-NKG2A MAB ENHANCES THE SUSCEPTIBILITY OF RHEUMATOID ARTHRITIS FIBROBLAST-LIKE SYNOVIOCYTES (FLS) TO NK CELL-MEDIATED CYTOTOXICITY

BLOCKING THE INHIBITORY CD94/NKG2A NK CELL RECEPTOR WITH A NOVEL ANTI-NKG2A MAB ENHANCES THE SUSCEPTIBILITY OF RHEUMATOID ARTHRITIS FIBROBLAST-LIKE SYNOVIOCYTES (FLS) TO NK CELL-MEDIATED CYTOTOXICITY

Bibliographic Details
Main Authors:	Nielsen, N, Galsgaard, E, Ahern, D, Andersen, M, Spee, P, Feldmann, M, Brennan, F, Soederstroem, K
Format:	Journal article
Published:	2012

Similar Items

Inhibitory NKG2A+ and absent activating NKG2C+ NK cell responses are associated with the development of EBV+ lymphomas
by: Hannes Vietzen, et al.
Published: (2023-06-01)

CD94/NKG2 is the predominant inhibitory receptor involved in recognition of HLA-G by decidual and peripheral blood NK cells.
by: Söderström, K, et al.
Published: (1997)

Cytotoxicity of CD56(bright) NK cells towards autologous activated CD4+ T cells is mediated through NKG2D, LFA-1 and TRAIL and dampened via CD94/NKG2A.
by: Natasja Nielsen, et al.
Published: (2012-01-01)

HLA-E is expressed on trophoblast and interacts with CD94/NKG2 receptors on decidual NK cells.
by: King, A, et al.
Published: (2000)

NKG2C+ NK Cells for Immunotherapy of Glioblastoma Multiforme
by: Shafiq Murad, et al.
Published: (2022-05-01)

The NK cell checkpoint NKG2A maintains expansion capacity of human NK cells
by: Meike Kaulfuss, et al.
Published: (2023-06-01)

Balance between activating NKG2D, DNAM-1, NKp44 and NKp46 and inhibitory CD94/NKG2A receptors determine natural killer degranulation towards rheumatoid arthritis synovial fibroblasts.
by: Nielsen, N, et al.
Published: (2014)

Responsiveness to Influenza Vaccination Correlates with NKG2C-Expression on NK Cells
by: Peggy Riese, et al.
Published: (2020-06-01)

Polyclonal Expansion of NKG2C+ NK Cells in TAP-deficient Patients
by: vivien eBeziat, et al.
Published: (2015-10-01)

High Metabolic Function and Resilience of NKG2A-Educated NK Cells
by: Andrew J. Highton, et al.
Published: (2020-09-01)

NKG2A is a NK cell exhaustion checkpoint for HCV persistence
by: Chao Zhang, et al.
Published: (2019-04-01)

Dissection of the NKG2C NK cell response against Puumala Orthohantavirus.
by: Hannes Vietzen, et al.
Published: (2021-12-01)

Chronic NKG2D Engagement In Vivo Differentially Impacts NK Cell Responsiveness by Activating NK Receptors
by: Christine Koch, et al.
Published: (2017-11-01)

Intratumoral co‐injection of NK cells and NKG2A‐neutralizing monoclonal antibodies
by: Ignacio Melero, et al.
Published: (2023-11-01)

Endothelial cells express NKG2D ligands and desensitize antitumor NK responses
by: Thornton W Thompson, et al.
Published: (2017-12-01)

Activating KIRs and NKG2C in viral infections: towards NK cell memory?
by: Mariella eDella Chiesa, et al.
Published: (2015-11-01)

A role for NKG2D in NK cell-mediated resistance to poxvirus disease.
by: Min Fang, et al.
Published: (2008-02-01)

Regulation of NK cell functions through interaction of the CD94/NKG2 receptors with the nonclassical class I molecule HLA-E.
by: Braud, V, et al.
Published: (1999)

Differential expression of NK receptors CD94 and NKG2A by T cells in rheumatoid arthritis patients in remission compared to active disease.
by: Ceara E Walsh, et al.
Published: (2011-01-01)

Improvement of NK Cell Cytotoxicity in Reconstituting NK Cells after Allogeneic Stem Cell Transplantation by Blocking NKG2A Checkpoint
by: Mohammed Taha, et al.
Published: (2023-10-01)

Macrophages help NK cells to attack tumor cells by stimulatory NKG2D ligand but protect themselves from NK killing by inhibitory ligand Qa-1.
by: Zhixia Zhou, et al.
Published: (2012-01-01)

Elusive Role of the CD94/NKG2C NK Cell Receptor in the Response to Cytomegalovirus: Novel Experimental Observations in a Reporter Cell System
by: Aldi Pupuleku, et al.
Published: (2017-10-01)

NK cell terminal differentiation: correlated stepwise decrease of NKG2A and acquisition of KIRs.
by: Vivien Béziat, et al.
Published: (2010-01-01)

NKG2D modulates aggravation of liver inflammation by activating NK cells in HBV infection
by: Yadong Wang, et al.
Published: (2017-03-01)

Elevated levels of cell-free NKG2D-ligands modulate NKG2D surface expression and compromise NK cell function in severe COVID-19 disease
by: Daniel Fernández-Soto, et al.
Published: (2024-02-01)

Activated NK cells reprogram MDSCs via NKG2D-NKG2DL and IFN-γ to modulate antitumor T-cell response after cryo-thermal therapy
by: Ping Liu, et al.
Published: (2022-12-01)

Bispecific NKG2D-CD3 and NKG2D-CD16 fusion proteins for induction of NK and T cell reactivity against acute myeloid leukemia
by: Melanie Märklin, et al.
Published: (2019-05-01)

NKG2D is a key receptor for recognition of bladder cancer cells by IL-2-activated NK cells and BCG promotes NK cell activation
by: Eva María García-Cuesta, et al.
Published: (2015-06-01)

NKG2D and DNAM-1 activating receptors and their ligands in NK-T cell interactions: role in the NK cell-mediated negative regulation of T cell responses
by: Alessandra eZingoni, et al.
Published: (2013-01-01)

High-throughput characterization of HLA-E-presented CD94/NKG2x ligands reveals peptides which modulate NK cell activation
by: Huisman, BD, et al.
Published: (2023)

High-throughput characterization of HLA-E-presented CD94/NKG2x ligands reveals peptides which modulate NK cell activation
by: Brooke D. Huisman, et al.
Published: (2023-08-01)

POTENTIAL USAGE OF NK CELLS AND NKG2D-POSITIVE LYMPHOCYTES AS TARGETS IN THERAPY OF CROHN’S DISEASE
by: E. A. Shulenina, et al.
Published: (2017-08-01)

Pseudorabies Virus Infection Causes Downregulation of Ligands for the Activating NK Cell Receptor NKG2D
by: Sofie Denaeghel, et al.
Published: (2021-02-01)

Autophagy-mediated NKG2D internalization impairs NK cell function and exacerbates radiation pneumonitis
by: Ruiqing Wang, et al.
Published: (2023-11-01)

Platelet-mediated shedding of NKG2D ligands impairs NK cell immune-surveillance of tumor cells
by: Stefanie Maurer, et al.
Published: (2018-02-01)

NKG2D and MICA/B shedding: a ‘tag game’ between NK cells and malignant cells
by: Samantha Xing, et al.
Published: (2020-01-01)

Distinctive CD56dim NK subset profiles and increased NKG2D expression in blood NK cells of Parkinson’s disease patients
by: Stephen Weber, et al.
Published: (2024-02-01)

Modified dendritic cell-derived exosomes activate both NK cells and T cells through the NKG2D/NKG2D-L pathway to kill CML cells with or without T315I mutation
by: Zhuanyun Du, et al.
Published: (2022-06-01)

Co-expression of IL-21-Enhanced NKG2D CAR-NK cell therapy for lung cancer
by: Yan Zhang, et al.
Published: (2024-01-01)

Human Metapneumovirus Escapes NK Cell Recognition through the Downregulation of Stress-Induced Ligands for NKG2D
by: Mohammad Diab, et al.
Published: (2020-07-01)